{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:36:17Z","timestamp":1792989377659,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Gothenburg","id":[{"id":"https:\/\/ror.org\/01tm6cn81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study aimed to evaluate methylphenidate-associated body mass index (BMI) changes and treatment discontinuation across weight status groups in children and adolescents, using real-world data.\u00a0We used data from the BMI Epidemiology Study (BEST) Gothenburg cohort linked to the Swedish National Prescribed Drug Register. We included children (&lt;\u200918 years) initiating methylphenidate, with BMI measurements available at baseline and one year. A subgroup also had BMI measurements at two years. We analysed changes in standardized BMI (zBMI) by baseline weight status and evaluated the impact of dosing and drug discontinuation.\u00a0Methylphenidate treatment was associated with significant zBMI reduction across all weight status groups in the first treatment year, with the largest decrease observed in those with obesity (-0.5 SD,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01). Higher dose increases, younger age, and female sex were associated with larger zBMI reductions. During the first year, obesity prevalence decreased from 10.4% to 5.7% (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), while underweight increased from 6.6% to 13.1% (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Individuals with underweight or normal weight had higher odds of discontinuation, compared with those with overweight or obesity (OR\u2009=\u20091.73,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.004). In the second year, zBMI and weight status remained largely stable.\u00a0In conclusion, in this real-world setting, methylphenidate was associated with BMI reductions across all weight status groups during the first treatment year. The greatest reduction was seen in individuals with obesity. For those continuing treatment the second year, BMI remained stable.\n                  <\/jats:p>","DOI":"10.1007\/s00787-026-03070-y","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:44:44Z","timestamp":1782539084000},"page":"3477-3486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of methylphenidate on body mass index in children and adolescents in relation to baseline weight status"],"prefix":"10.1007","volume":"35","author":[{"given":"Julia","family":"Izsak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin E.","family":"Kimland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Martikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Dahl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Halldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny M.","family":"Kindblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"1","key":"3070_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12888-021-03547-x","volume":"21","author":"I Rocco","year":"2021","unstructured":"Rocco I et al (2021) Time of onset and\/or diagnosis of ADHD in European children: a systematic review. BMC Psychiatry 21(1):575","journal-title":"BMC Psychiatry"},{"issue":"1","key":"3070_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12916-019-1449-8","volume":"17","author":"M Di Cesare","year":"2019","unstructured":"Di Cesare M et al (2019) The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action. BMC Med 17(1):212","journal-title":"BMC Med"},{"issue":"1","key":"3070_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1176\/appi.ajp.2015.15020266","volume":"173","author":"S Cortese","year":"2016","unstructured":"Cortese S et al (2016) Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis. Am J Psychiatry 173(1):34\u201343","journal-title":"Am J Psychiatry"},{"issue":"1","key":"3070_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41398-021-01584-4","volume":"11","author":"V Karhunen","year":"2021","unstructured":"Karhunen V et al (2021) The link between attention deficit hyperactivity disorder (ADHD) symptoms and obesity-related traits: genetic and prenatal explanations. Transl Psychiatry 11(1):455","journal-title":"Transl Psychiatry"},{"issue":"3","key":"3070_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1087054716669589","volume":"22","author":"JT Instanes","year":"2018","unstructured":"Instanes JT et al (2018) Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review. J Atten Disord 22(3):203\u2013228","journal-title":"J Atten Disord"},{"issue":"6","key":"3070_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.mehy.2007.10.012","volume":"70","author":"LL Liu","year":"2008","unstructured":"Liu LL et al (2008) Does dopaminergic reward system contribute to explaining comorbidity obesity and ADHD? Med Hypothes 70(6):1118\u201320","journal-title":"Med Hypothes"},{"issue":"7","key":"3070_CR7","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s41386-019-0592-4","volume":"45","author":"NR Mota","year":"2020","unstructured":"Mota NR et al (2020) Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit\/Hyperactivity Disorder and obesity measures. Neuropsychopharmacology 45(7):1188\u20131195","journal-title":"Neuropsychopharmacology"},{"key":"3070_CR8","unstructured":"European Medicines Agency [Internet]. Available from: https:\/\/www.ema.europa.eu. Accessed 21 Aug (2025)"},{"key":"3070_CR9","unstructured":"Guidelines of the Swedish Association for Child and Adolescent Psychiatry [Internet]. Available from: https:\/\/slf.se\/sfbup\/riktlinjer\/. Accessed 21 Aug (2025)"},{"issue":"2","key":"3070_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1542\/peds.86.2.184","volume":"86","author":"RA Barkley","year":"1990","unstructured":"Barkley RA et al (1990) Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 86(2):184\u2013192","journal-title":"Pediatrics"},{"issue":"4","key":"3070_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1542\/peds.100.4.662","volume":"100","author":"D Efron","year":"1997","unstructured":"Efron D, Jarman F, Barker M (1997) Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 100(4):662\u2013666","journal-title":"Pediatrics"},{"issue":"2","key":"3070_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/1087054718808045","volume":"24","author":"E Mellstr\u00f6m","year":"2020","unstructured":"Mellstr\u00f6m E et al (2020) Methylphenidate and Reduced Overweight in Children With ADHD. J Atten Disord 24(2):246\u2013254","journal-title":"J Atten Disord"},{"issue":"10","key":"3070_CR13","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1111\/apa.15881","volume":"110","author":"K Fast","year":"2021","unstructured":"Fast K et al (2021) Half of the children with overweight or obesity and attention-deficit\/hyperactivity disorder reach normal weight with stimulants. Acta Paediatr 110(10):2825\u20132832","journal-title":"Acta Paediatr"},{"issue":"9","key":"3070_CR14","doi-asserted-by":"publisher","first-page":"e13058","DOI":"10.1111\/ijpo.13058","volume":"18","author":"SR Kollin","year":"2023","unstructured":"Kollin SR, Lim CS, Lee AA (2023) The longitudinal influence of ADHD status and stimulant medication on body mass index and blood pressure among youth with obesity. Pediatr Obes 18(9):e13058","journal-title":"Pediatr Obes"},{"key":"3070_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jpeds.2021.09.030","volume":"241","author":"JG Waxmonsky","year":"2022","unstructured":"Waxmonsky JG et al (2022) Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder. J Pediatr 241:115\u2013125e2","journal-title":"J Pediatr"},{"issue":"3","key":"3070_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/0883073810380051","volume":"26","author":"G Dubnov-Raz","year":"2011","unstructured":"Dubnov-Raz G, Perry A, Berger I (2011) Body mass index of children with attention-deficit\/hyperactivity disorder. J Child Neurol 26(3):302\u2013308","journal-title":"J Child Neurol"},{"key":"3070_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-025-00728-z","author":"J Izsak","year":"2025","unstructured":"Izsak J et al (2025) Dosing and discontinuation of Methylphenidate medication in relation to weight status in children and adolescents. Paediatr Drugs. https:\/\/doi.org\/10.1007\/s40272-025-00728-z","journal-title":"Paediatr Drugs"},{"issue":"12","key":"3070_CR18","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1111\/apa.16089","volume":"110","author":"M Bygdell","year":"2021","unstructured":"Bygdell M et al (2021) Prevalence of overweight and obesity from 5 to 19 years of age in Gothenburg, Sweden. Acta Paediatr 110(12):3349\u20133355","journal-title":"Acta Paediatr"},{"key":"3070_CR19","unstructured":"Guidelines for ATC classification and DDD assignment. WHO Collaborating Center for Drug Statistical Methodology. Oslo, 2024."},{"issue":"7244","key":"3070_CR20","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","volume":"320","author":"TJ Cole","year":"2000","unstructured":"Cole TJ et al (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320(7244):1240\u20131243","journal-title":"BMJ"},{"issue":"7612","key":"3070_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/bmj.39238.399444.55","volume":"335","author":"TJ Cole","year":"2007","unstructured":"Cole TJ et al (2007) Body mass index cut offs to define thinness in children and adolescents: international survey. BMJ 335(7612):194","journal-title":"BMJ"},{"issue":"4","key":"3070_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.2047-6310.2012.00064.x","volume":"7","author":"TJ Cole","year":"2012","unstructured":"Cole TJ, Lobstein T (2012) Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes 7(4):284\u2013294","journal-title":"Pediatr Obes"},{"issue":"8","key":"3070_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1089\/cap.2017.0163","volume":"28","author":"YE Lentferink","year":"2018","unstructured":"Lentferink YE et al (2018) Psychostimulants: influence on Body Mass Index and height in a pediatric population with Attention-Deficit\/Hyperactivity Disorder? J Child Adolesc Psychopharmacol 28(8):530\u2013536","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8","key":"3070_CR24","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2016-1885","volume":"101","author":"T Reinehr","year":"2016","unstructured":"Reinehr T et al (2016) Which amount of BMI-SDS reduction is necessary to improve cardiovascular risk factors in overweight children? J Clin Endocrinol Metab 101(8):3171\u20139","journal-title":"J Clin Endocrinol Metab"},{"issue":"4 Pt 1","key":"3070_CR25","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1542\/peds.98.4.763","volume":"98","author":"M Schertz","year":"1996","unstructured":"Schertz M et al (1996) Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Pediatrics 98(4 Pt 1):763\u2013769","journal-title":"Pediatrics"},{"issue":"9","key":"3070_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","volume":"5","author":"S Cortese","year":"2018","unstructured":"Cortese S et al (2018) Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 5(9):727\u2013738","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"3070_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/10870547241293946","volume":"29","author":"L Dalnoki","year":"2025","unstructured":"Dalnoki L et al (2025) Exploring the Relationship of Dietary Intake With Inattention, Hyperactivity, and Impulsivity, Beyond ADHD. J Atten Disord 29(1):70\u201379","journal-title":"J Atten Disord"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03070-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03070-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03070-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:23:42Z","timestamp":1792988622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03070-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3070"],"URL":"https:\/\/doi.org\/10.1007\/s00787-026-03070-y","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of the University of Gothenburg, Sweden (D-nr 013-10, on 28 January 2010) with several amendments.","order":1,"name":"Ethics","label":"Ehics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. EEK is employed by the Swedish Medical Products Agency. The views expressed in this study are the personal views of the authors and not necessarily the view of the government agency.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}